JP2002233331A - Health supplement having bloodstream disorder ameliorating action - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a composition capable of preventing the occurrence of bad blood, removing the bad blood with a preventive medicine, and preventing the blood retention by making the blood flow smooth. SOLUTION: This composition consists mainly of natural products having no fear of side effects; wherein crude drug ingredients having actions of expanding the blood vessels, regulating blood pressure and lowering blood viscosity, and an antioxidant eliminating activated oxygen causing bad blood are formulated. More specifically, the composition consists mainly of herba erigerontis ginkgo leaves, and panax notoginseng which are regarded, from ancient times, as having an action of eliminating bad blood by increasing blood flow volume, and astaxanthin having a high antioxidant action preventing generation of bad blood, and is properly formulated with Schinopsis lerentzii leaves, Mucunae Caulis, Kouko (Acromichia Pedunculata), Crataegi Fructus, curcumae rhigoma, Carthamus tinctorius, Cinnamomum cassia, ginger, aurantii nobllis pericarpium and Panax ginseng.

Description

DETAILED DESCRIPTION OF THE INVENTION

[0001]

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a health supplement having an effect of improving blood circulation disorders.

[0002]

2. Description of the Related Art In recent years, not only thrombosis and infarction in the elderly but also so-called younger lifestyle-related diseases have become a social problem. The causes of these blood circulation disorders are as follows.
It is considered that the influence of lifestyle changes such as westernization of the diet such as diabetes, hypertension and hyperlipidemia is great. The cause of these diseases is called o-blood which means stagnant blood in Chinese traditional medicine, and this o-blood is considered to cause a wide range of diseases such as arteriosclerosis, diabetes, cancer, and dementia.

In ancient times, Chinese ginseng, a Lamiaceae plant, has been used as an agent for improving this blood, but since the 1970s, it has been a chrysanthemum plant whose main production area is Yunnan, China. Lansanus has attracted attention as showing high medicinal effects. In pharmacological studies, lanterns have the effect of dilating cerebral and coronary blood vessels, increasing local blood circulation by increasing blood flow, and reducing vascular resistance and reducing myocardial oxygen. It has been reported to have an effect of reducing wasting (Medicinal Pharmaceutical Research 1985, (2): 25). In recent years, attention has been paid to such medicinal effects in Japan, and a composition for improving blood circulation, which mainly comprises Lanthanum and Dansin, has been proposed (JP-A-10-236966). However, all of these drugs are intended to eliminate the stagnation of blood flow by increasing blood flow due to dilation of blood vessels, adjustment of blood pressure and reduction of blood viscosity.

[0004]

In recent years, it has become clear that active oxygen in the body is deeply involved in increasing blood flow resistance, increasing blood viscosity, and the like. In other words, active oxygen damages the endothelial cells of blood vessels, resulting in aggregation of platelets, increasing blood flow resistance, inducing hypertension, and increasing blood viscosity by oxidizing blood fats. It has become clear that it causes defects. Therefore, the above-mentioned conventional composition attempts to remove the stagnation of blood by increasing the blood flow based on a symptomatic treatment idea, so that a fundamental treatment including the cause of blood can be performed. It wasn't. The present invention relates to the scope of the symptomatic treatment for blood as described above, provided that the purpose of blood removal is from a preventive medical point of view, which is to prevent the occurrence of various medical conditions caused by blood. In view of the fact that it is necessary to obtain a composition capable of preventing the occurrence of blood itself, the present invention aims to obtain a composition having such an action.

[0005]

The dietary supplement according to the present invention for achieving the above object is a composition containing a natural product as a main component which has no fear of side effects. It is characterized by blending a crude drug component having an action of reducing the amount of antioxidant and an antioxidant for removing active oxygen that causes blood loss. The crude drug component having the effect of dilating the blood vessels, adjusting blood pressure and decreasing blood viscosity includes crude drugs such as Lanthanum or Dansin, which have long been considered to have the effect of removing blood by increasing blood flow. It is preferable to mix astaxanthin, which has a high antioxidant action, as a substance for preventing the occurrence of blood. The synergistic effect of each of these components not only is effective in treating o-blood as a symptomatic treatment, but is also a health supplement that can more fundamentally prevent the generation of o-blood.

[0006]

DETAILED DESCRIPTION OF THE INVENTION More specifically, the main constituents are Lansanka, Ginkgo biloba, Three Ginseng, and Astaxanthin, which are composed of Dansan Leaf, Chicken Blood Fuji, Fuka, Yamashiko, Ikukin, Safflower, Cinnamon, Ginger, Chen skin and ginseng are added as appropriate. Lansanka has an effect of improving cerebral blood flow, increasing arterial blood flow, lowering blood pressure, inhibiting platelet aggregation and improving microcirculation, and is highly effective in improving myocardial infarction, angina, and sequelae of stroke. Ginkgo biloba is effective in preventing blurring and improving vascular circulation by strengthening capillaries, expanding blood vessels, and promoting blood flow. Ginseng has anticoagulant, blood pressure regulating and antioxidant effects and is considered good for angina pectoris, cerebral hemorrhage, autonomic imbalance, reduced fertilization and coronary artery disease. Astaxanthin is compared to vitamin E by 100% depending on the concentration.
It has a high active oxygen removing action of up to 1000 times (Patent No. 261991, FIG. 4 and its description), and prevents an increase in blood viscosity due to diabetes, hyperlipidemia, etc.
Prevent the occurrence of vascular disorders.

Further, the action of the components to be added to these is as follows. Dansin leaf has vasodilation, cerebral blood flow increase, anticoagulation, and blood pressure lowering effects, and has been used as a crude drug for improving blood loss since ancient times. Chicken blood wisteria has blood circulation improvement, confounding (anti-rheumatic), hematopoietic promoting effects, and is effective for angina pectoris. Fragrance promotes blood flow and has a hemostatic effect. Yamako is said to have the effects of vasodilation, lowering blood pressure, and reducing blood fat, and is good for instinct and promotion of digestion. Ikukin improves hemostasis, secretes bile and promotes liver detoxification. Takes congestion and heals physiology and hepatitis. Safflower has the effects of improving microcirculation, anticoagulation, and activation of enzymes in brain tissue, and is good for vital blood, menstruation, blood purification, and blood pressure lowering. Cinnamon has vasospasm relieving action and promotes blood circulation. Ginger has a blood pressure lowering and bactericidal action. Tangerine
(Chen) has a peripheral vasoconstrictor action. Ginseng has the effect of increasing blood flow by increasing blood vessel elasticity and lowering blood sugar levels.

An example of the mixing ratio of the above components is as follows. Astaxanthin 1.5 to 9.0% by weight Ginkgo biloba 1.5 to 9.0% by weight Ginseng 6.0 to 20.0% by weight Yamako 1.5 to 5.0% by weight Dansin leaves 1.5 to 7 1.0% by weight Lansanka 15.0-50.0% by weight Chicken wisteria 1.5-5.0% by weight Ikukin 1.0-3.5% by weight Safflower 1.5-5.0% by weight Seeds Ginseng 0.5-3.0% by weight Fragrance 1.0-3.5% by weight Ginseng 0.5-3.0% by weight Ginger 0.2-3.5% by weight Ginseng 0.2-3.5% by weight % Excipient Remaining

[0009]

EXAMPLE A patient who falls on a bicycle and hits his head complaining of a headache O. (43 years old) showed a remarkable decrease in cerebral blood flow as a result of the diagnosis. Three months after taking the health food according to the following prescription 1, the patient had a diagnosis that his headache had improved but his cerebral blood flow was still poor. Therefore, as a result of switching to prescription 2 from the fourth month, cerebral blood flow was improved. It was recognized that the difference between the actions of Formula 1 and Formula 2 was due to the action of Lansanum, and it was shown that the composition of the present invention exhibited a high effect even with such a simple formula.

[0010] Based on these several dosage examples, Formulation 2 was used as a basic composition, and Formulation 3 was obtained as an example of a formulation obtained by blending the various components described above.

As a result of taking the composition of Formula 3 three times three times, that is, nine times a day, remarkable improvement was observed in the following wide-ranging symptoms. 45 years old Y. He was diagnosed with ischemic heart disease from smoking too much and drinking too much alcohol, and was called angina.
Three months after taking the drug, angina improved, and the doctor was surprised. 70 years old T. T. Although she was very dizzy and numb, her cerebral blood flow increased two months after taking the drug, and her blood pressure, which had been 190, had fallen to 135. 60 years old K. S. She received steroids at the hospital and continued drinking for three years, but she did not have any pain from rheumatoid arthritis. Six months after taking the drug, the pain of rheumatoid arthritis eased and walking became easier. 68 years old T. He had a cerebral infarction, which was attributed to uneven diet and overwork. Four months after taking the medicine, doctors were surprised that the sequelae of cerebral infarction had become lighter and the oxygen level in the brain had increased. 55 years old N. I couldn't remove the stiffness even if I put on it and rub it. One month after taking the drug, stiff shoulders cleared up. 65 years old K. She was diagnosed with diabetes six months ago. Four months after taking the drug, the blood sugar level had dropped and cholesterol had also dropped. 23 years old S. Originally she was cold and had severe menstrual pain. However, two months after taking the drug, he had a terrible menstrual cycle. 28 years old K. I. He had irregular meals at night, smoked 60 cigarettes a day, and felt pain in his chest. The piercing pain in the chest disappeared two months after taking the drug. 33 years old I. T. The steel pipe hit the construction site, and the bruise did not improve. Three months after taking it, her bruises became clear. 45 years old K. He liked alcohol and his liver was weak. γG
The TP also sometimes exceeded 80. Two months after taking the kuma, the area around my eyes was removed. 56 years old M. Numbness continued with myocardial infarction. 1
The numbness in my hands and feet disappeared in the month. 38 years old N. Hepatic treatments prescribed by doctors did not help. Three months after taking the drug, his liver function improved and his erythema on his hand disappeared. 30 years old Y. O. She was taking vitamin E, but she didn't get cold. One month after the administration, the limbs became cold. 57 years old T. Y. His blood pressure rose to over 180, his stiff shoulders were severe, and his physical condition was poor. Five months after taking the medicine, a doctor told me that the blood vessels, which had been called arteriosclerosis, were getting better. 36 years old K. T. When blood pressure began to rise, tinnitus became severe. One month after taking the drug, my ear stopped completely.

[0012]

The dietary supplement of the present invention can improve cerebral blood flow, increase arterial blood flow,
Hypotensive action, vasodilator action, activation of enzymes in brain tissue,
It has been found that it has an excellent effect on all diseases and symptoms derived from blood, such as improvement of microcirculation and improvement of hyperlipidemia.

──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. ⁷ Identification symbol FI Theme coat ゛ (Reference) A61K 35/78 A61K 35/78 H TK 45/06 45/06 A61P 9/00 A61P 9/00 F term (Ref.) ZA75 ZB15 ZB35 ZC33 ZC35 ZC80 4C206 AA01 AA02 CB25 MA03 MA72 NA14 ZA36 ZA39 ZA40 ZA42 ZA53 ZA54 ZA70 ZA75 ZB15 ZB35 ZC33 ZC35 ZC80

Claims (5)

[Claims] 1. A dietary supplement having an effect of improving blood circulation disorders, comprising a crude drug component having the effects of expanding blood vessels, adjusting blood pressure and decreasing blood viscosity, and an antioxidant. 2. The health supplement having the action of improving blood circulation disorders, characterized in that the crude drug component having the actions of dilating blood vessels, regulating blood pressure and decreasing blood viscosity according to claim 1 is Lansanana and / or Dansin. Food 3. The dietary supplement as claimed in claim 1, wherein the antioxidant is astaxanthin. 4. Main constituents are Lansanka, Ginkgo biloba, 37 ginseng, and astaxanthin, to which are ginseng leaves, chicken blood wisteria, fuka, Yamashiko, Ikukin, safflower, cinnamon, ginger, ginseng, and ginseng. A dietary supplement having an action of improving blood circulation disorders characterized by being appropriately blended 5. Astaxanthin 1.5 to 9.0% by weight, Ginkgo biloba 1.5 to 9.0% by weight, Ginseng 6.0 to 2%
0.0% by weight, Yamako 1.5-5.0% by weight, Dansin leaf 1.5-7.0% by weight, Lansanka 15.0-50.0% by weight, Chicken wisteria 1.5-5. 0% by weight, Ikukin 1.0-3.5
Weight%, safflower 1.5-5.0 weight%, ginseng 0.5-
3.0% by weight, Fragrance 1.0-3.5% by weight, Cinnamon 0.5
~ 3.0% by weight, ginger 0.2 ~ 3.5% by weight, Chen skin 0.
A dietary supplement comprising 2 to 3.5% by weight of the remainder of the excipient and having an effect of improving blood circulation disorders.